AME vs EOLS · P/E 30, rev $7.40B vs rev $266.3M
Ametek Inc (AME) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
AME currently screens at market cap $42.11B and trailing P/E 29.9. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the AME and EOLS stock pages for the full models.
Not investment advice.